Science News

BELLINGHAM, Wash.--(BUSINESS WIRE)--The AR Alliance, a division of SPIE focused on augmented reality (AR), proudly announces the addition of AlphaLum, Appotronics, Augmenteum, CREAL, EyeJets, GIS, Gixel, Goertek, Kyocera SLD Laser, Nichia America Corporation, OORYM Optics, OQmented, RAONTECH, Solnil, TDK, TechnoTeam, TriLite Technologies, and University of Rochester to its membership. Members of the AR Alliance reflect the global diversity and strength of the AR hardware development ecosystem,...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Covenant Capital Group (“Covenant”), a leading value-add multifamily real estate investment firm, today announced the final close of Covenant Apartment Fund XII, L.P. (“Fund XII”) with $860.35 million in capital commitments—the largest fundraise in the firm’s 25-year history. In addition, Covenant created a sidecar vehicle for Fund XII, the Covenant Affordable Housing Fund, with $269.73 million in committed capital. The combined capital raised by Covenant for...

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin’s Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin’s science-led innovations — from ageLOC® technology to t...

LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced a successful live demonstration with Quantum Corridor showing how critical digital infrastructure can stay precisely synchronized without relying on GPS. Quantum Corridor is a quantum-safe, ultra-fast, and highly secure fiber-optic network in the Midwest enabling next-generation communication. The demonstration was conducted across 21.8 kil...

BOSTON--(BUSINESS WIRE)--Atrandi Biosciences announced it will present new scientific data and platform innovations at the SLAS2026 International Conference and Exhibition...

SAN FRANCISCO--(BUSINESS WIRE)--Terradot, an enhanced rock weathering (ERW) carbon removal company, today announced it has agreed to acquire assets of Eion, a U.S.-based ERW company known for pioneering olivine-based deployments and an early track record of technical innovation, including some of the first issued ERW credits. Enhanced rock weathering accelerates a natural process to durably remove carbon dioxide from the atmosphere. Crushed minerals like basalt or olivine are applied to farms a...

BEVERLY, Mass.--(BUSINESS WIRE)--HighRes® today announced a new brand identity and technology direction at SLAS2026, marking a pivotal evolution from building reliable automation platforms to delivering intelligent, accessible laboratory systems designed for the next era of scientific discovery. For more than two decades, HighRes has quietly powered some of the world’s most advanced laboratories, earning trust by delivering automation systems that work, last, and perform when failure is not an...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces its participation in the Association for Research in Otolaryngology (ARO) 49th Annual Midwinter Meeting, taking place on February 7-11, 2026, in San Juan, Puerto Rico. Arnaud Giese, Ph.D., Group Leader for Animal Pharmacology Platform at Senso...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking clinical data from the nPulse Cardiac Catheter first-in-human feasibility study. The study demonstrates successful treatment of atrial fibrillation in 150 patients with rapid procedure times and minimal adverse effects. The data were presented today at the 31st Annu...

PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)...